autologous tumor cell vaccine

autologous tumor cell vaccine information and resources from the National Cancer Institute

NCI Thesaurus | autologous tumor cell vaccine

A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the vaccine is then administered to the individual from whom the tumor cells were isolated. Typically combined with an adjuvant immunostimulant, an autologous cell vaccine may elicit a cytotoxic T-lymphocytic immune response to cell surface-expressed tumor-associated antigens (TAAs), resulting in tumor cell death. NCI Thesaurus | autologous tumor cell vaccine

A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the vaccine is then administered to the individual from whom the tumor cells were isolated. Typically combined with an adjuvant immunostimulant, an autologous cell vaccine may elicit a cytotoxic T-lymphocytic immune response to cell surface-expressed tumor-associated antigens (TAAs), resulting in tumor cell death.

autologous tumor cell vaccine -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org